Cytokeratin-18 (CK-18) (Western Blot Control) from RANDOX LABORATORIES LTD.
Search, find, compare suppliers for Cytokeratin-18 (CK-18) (Western Blot Control) products.
| Edit | |
|---|---|
| Product Name | Cytokeratin-18 (CK-18) (Western Blot Control) |
| Description | Purity Single band on Western blot. Tissue polypeptide specific antigen was first identified as a tumour marker in the late 1950's, but has recently been shown to be closely related to human cytokeratin 18. Cytokeratins are a group of about 20 cytoskeletal proteins, whose degradation gives rise to soluble fragments, measurable in the blood of patients. Serum levels are high in breast cancer patients and also some other malignancies, probably due to high cell turnover in tumours. RANDOX recombinant CK-18 comprises a 430 amino acid fragment (1-430) corresponding to the mature CK-18 protein and is expressed in E. coli with an amino-terminal hexahistidine tag. This product is for research use only and is not intended for diagnostic or therapeutic use. |
| Size | 10µg |
| Concentration | n/a |
| Applications | RUO |
| Other Names | Recombinant protein. CK-18, Keratin 18 |
| Gene, Accession, CAS # | n/a |
| Catalog # | RCP9215 |
| Price | $135 |
| Order / More Info | Cytokeratin-18 (CK-18) (Western Blot Control) from RANDOX LABORATORIES LTD. |
| Product Specific References | D'Alessandro, R. et al. (2001) Breast Cancer Res. Treat. 68(1): 9-19 |
RANDOX LABORATORIES LTD.
RANDOX LABORATORIES LTD.
55 Diamond Road,
Crumlin, County Antrim, BT29 4QY UNITED KINGDOM
P: +44 (0) 28 9442 2413
https://www.randox.com/bioreagents-overview/
Profile of RANDOX LABORATORIES LTD.